A ll-cause mortality risk has seldom been compared between the period up to and the period after coronary heart disease (CHD) and stroke. Such unified epidemiological approach allows quantifying the effect of CHD and stroke events on all-cause mortality relative to a baseline risk period. We addressed this issue within the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
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Methods

Study Population and Case Ascertainment
The study population comprised 10 424 men 50 to 59 years of age who were recruited in 1991-1994 from 4 WHO MONICA centers in France (N=7855) and Northern Ireland (N=2747) and followed up for all-cause mortality over 10 years. 1 Incident CHD (stable and unstable angina, myocardial infarction, and coronary death) and ischemic stroke events were adjudicated as reported previously.
1,2
Study Periods
All-cause mortality in the period up to CHD and stroke, including deaths that occurred within 28 days of such events, was investigated in the entire study population. All cause mortality in the period after CHD or stroke was investigated in those who survived >28 days after such events. 
Results
Mean age was 54.90 (SD 2.89) years. During follow-up, 741 men experienced CHD, 104 stroke, and 28 both events; 9551 remained free of CHD and stroke.
All-Cause Mortality Rates
In the period up to CHD and stroke, 569 deaths occurred, including 494 among men who remained free of CHD and stroke. In the period after CHD and stroke, 66 deaths occurred among 798 men who survived at least 28 days after their event.
The crude annual all-cause mortality rates by study periods are reported in Table 1 , overall and by subgroups.
Hazard Ratios of All-Cause Mortality
After adjustment for cardiovascular risk factors and country (Model 1), hazard ratios of all-cause mortality were 1.58 (95% confidence interval 1.18-2.12) after CHD and 3.13 (95% confidence interval 1.98-4.92) after stroke ( Table 2) . Associations remained virtually unchanged after adjustment for socioeconomic characteristics, physical activity, and depressive symptoms. The increased risk of all-cause mortality after CHD and stroke was consistent across strata examined ( Figure) .
Discussion
Previous authors investigated either the short-term all-cause mortality after CHD and, to a lesser extent, after stroke or the long-term prognosis after CHD and stroke. We extend these investigations by dissociating periods up to from periods after CHD and stroke events within the same study population over a long follow-up. This approach allowed us to evaluate the effect of cardiovascular disease events on the subsequent risk of all-cause mortality in the context of a baseline risk period in a given population. In the present study, the stronger effect of intercurrent stroke as compared with CHD events on all-cause mortality risk may first be driven by age, although mean age at CHD and stroke events was similar in the PRIME study and survival models were age-adjusted. It may also reflect a gap in acute care, pharmacotherapy, rehabilitation, and recovery between CHD and stroke patients. Urgent revascularization strategies were first applied in the late 1980s among patients with acute coronary syndromes as compared with the early 2000s in ischemic stroke patients. 5 Despite the rapid implementation of acute revascularization strategies in the management of stroke, to date a limited proportion of patients presenting in clinical practice are eligible for such treatment. 6 Finally, stroke events are a major cause of disability in adults, which may contribute to the higher risk of death after stroke compared with CHD. 7 We conclude that a substantial increase in all-cause mortality was observed after the occurrence of CHD and even more after stroke in comparison to a baseline period. These results reinforce the major importance of primary and secondary prevention of cardiovascular disease. They also raise the issue of organizing acute care, particularly the dissemination of stroke units and multidisciplinary teams with cerebral revascularization facilities.
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SUPPLEMENTAL MATERIAL
The estimated hazard ratios and 95% confidence intervals compare the risk of allcause mortality between the period following CHD or stroke and the period up to such events. Cox's proportional hazards regression analyses were systematically adjusted for coronary heart disease and stroke event used as time dependent covariates and additional adjustments were sequentially made as detailed below:
Simple Model simultaneously and solely adjusted for coronary heart disease and stroke events (time dependent covariates). Model 1 (classical risk factors and country): simple Model + age, smoking status, systolic blood pressure, heart rate, body mass index, alcohol consumption, waist on hip ratio, personal history of cardiovascular disease, total and high density lipoprotein cholesterol, antidiabetic, antihypertensive and lipid lowering medications, and country Model 2 (socioeconomic characteristics): model 1 + educational level, living with a partner and employment status. Model 3 (physical activity): model 1 + physical activity. Model 4 (depressive symptoms): model 1+ 13-items Centre for Epidemiological Studies-Depression score and antidepressants.
